• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR CP FT4; RADIOIMMUNOASSAY, FREE THYROXINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR CP FT4; RADIOIMMUNOASSAY, FREE THYROXINE Back to Search Results
Model Number N/A
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 11/01/2016
Event Type  malfunction  
Manufacturer Narrative
The cause for the discordant advia centaur cp ft4 results is unknown.Siemens healthcare diagnostics has requested that remaining readypacks from lot 073 be sent to siemens for additional testing.The interpretation of results section of the instructions for use states: "results of this assay should always be interpreted in conjunction with patient's medical history, clinical presentation and other findings.".
 
Event Description
Customer observed elevated advia centaur cp ft4 results that did not match the clinical picture or the results from another lot of reagents for two patient samples.There are no reports that treatment was altered or prescribed or adverse health consequences due to the elevated advia centaur cp ft4 results.
 
Manufacturer Narrative
Siemens filed mdr 1219913-2016-00218 on november 18, 2016 reporting advia centaur cp ft4 results that did not match the clinical picture or the results from another lot of reagents for two pt samples.On (b)(6) 2016 simens performed a study with bio-rad controls of lot 40310 and pt samples with advia centaur cp ft14 reagent lot 073 and calibrator a lot 90.Results: 40311 - 0.880 ng/ml, 40312 - 2.31 ng/ml, 40313 - 3.69 ng/ml.Controls are in range: 40 samples were tested with advia centaur ft4 reagent lots 073 and 074 and calibrator a lot 90.The mean bias between the two reagent lots was 3.4% and median bias was 3.3% and the normal range was verified.The customer will send in unused ready packs of reagent lot 073 for siemens to further investigate.
 
Manufacturer Narrative
Mdr 1219913-2016-00218 was filed on november 18, 2016 reporting elevated advia centaur cp ft4 results that did not match the clinical picture or the results from another lot of reagents for two patient samples.Mdr 1219913-2016-00218 supplemental 1 was filed on december 19, 2016 with initial results of siemens investigation.January 18, 2017 - additional information and evaluation results customer reported that they are using advia centaur cp ft4 reagent lot 75 and calibrator a lot 90 and all qc levels are in range and close to the mean.Ft4 qc data: lot#075/ca90; l1=0.81 (b)(6) 2017; cust range=0.61-1.01; l2=2.27 (b)(6) 2017; cust range=1.76-2.76; l3=3.59 (b)(6) 2017; cust range=2.94-4.60.Siemens received two additional readypacks of advia centaur ft4 lot 073 from the customer and tested them side by side with one internal readypack of lot 073 and one readypack of lot 074 with qc and patient samples.The percent difference to target of the qc results are below.In-house readypacks customer returned readypacks lot 073 : lot 074: lot 073 #1: lot 073 #2: (b)(6) 3.7; -2.5; 27.0; 21.8.(b)(6) -0.4; -4.0; 16.2; 16.9.(b)(6) -0.1; -5.8; 14.0; 12.9.The percent difference to target results shows a marked increase compared to the in-house readypacks for the patient samples the percent differences to the lot 073 in-house readypack results were calculated for the other three readypacks.Results are below.074 in-house customer 073 #1 customer 073 #2 (b)(6).Results from controls and patient samples confirm the customers observation of high results on the customer returned lot 073 readypacks only.The in-house lot 073 readypack tested did not show the same high results.A possible root cause could be improper shipping of the readypacks.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CENTAUR CP FT4
Type of Device
RADIOIMMUNOASSAY, FREE THYROXINE
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
tarrytown NY 10591
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS, INC
333 coney street
east walpole MA 02032
Manufacturer Contact
louise mclaughlin
333 coney street
east walpole, MA 02032
5086604381
MDR Report Key6113204
MDR Text Key60435333
Report Number1219913-2016-00218
Device Sequence Number1
Product Code CEC
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K132249
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Health Professional
Remedial Action Inspection
Type of Report Initial,Followup,Followup
Report Date 02/06/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/18/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/25/2017
Device Model NumberN/A
Device Catalogue Number10282218
Device Lot Number46879073
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/18/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-